Risk of major cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: retrospective cohort analyses using routine, de-identified data from South Africa

Conference Reports for NATAP

IAS
25th International AIDS Conference
22 to 26 July 2024


Risk of major cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: retrospective cohort analyses using routine, de-identified data from South Africa

	AIDS 2024 July 20-26 Munich